Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 12/20 | 0.68 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | CTSV | O60911 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4781390 | 1.00 | SLC6A9 (0.68) | SLC6A9P2RX7MAPK1CTSSCTSV | |
| SCHEMBL4782501 | 0.98 | SLC6A9 (0.72) | SLC6A9P2RX7MAPK1CTSS | |
| SCHEMBL4782505 | 0.98 | SLC6A9 (0.72) | SLC6A9P2RX7MAPK1CTSS | |
| SCHEMBL4782486 | 0.98 | SLC6A9 (0.72) | SLC6A9P2RX7MAPK1CTSS | |
| SCHEMBL4778895 | 0.93 | SLC6A9 (0.70) | SLC6A9P2RX7MAPK1CTSSCTSK | |
| SCHEMBL4778901 | 0.93 | SLC6A9 (0.70) | SLC6A9P2RX7MAPK1CTSSCTSK | |
| SCHEMBL4781588 | 0.91 | SLC6A9 (0.75) | SLC6A9P2RX7MAPK1CTSSCTSK | |
| SCHEMBL4781578 | 0.91 | SLC6A9 (0.75) | SLC6A9P2RX7MAPK1CTSSCTSK | |
| SCHEMBL4781583 | 0.91 | SLC6A9 (0.75) | SLC6A9P2RX7MAPK1CTSSCTSK | |
| SCHEMBL8224340 | 0.90 | SLC6A9 (0.73) | SLC6A9P2RX7CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008018639-A2 | GLYCINE TRANSPORTER INHIBITOR | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-02-14 | — | — | WO | disclosed |